drugset / Trial / NCT01453179

Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses (LEIDA 2)

NCT01453179

RandomizedParallel-groupOpen-labelTreatment

Summary

This clinical trial serves the purpose to compare the long-term effects of a treatment of actinic keratosis - your skin disorder - using Aldara® 5% cream (Imiquimod) or Solaraze® 3% gel (Diclofenac) on the face or the scalp. In particular, it should be found out whether the healing effect of these two medications on the skin lesions (i.e. the damaged skin parts) can be maintained for a prolonged period.

Timeline

Start
2011-10
Primary completion
2015-03
Completion
2015-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Diclofenac Other / unclassified 3 % Topical
Comparator Diclofenac Other / unclassified 0.5 g Topical
Subject Imiquimod Other / unclassified 5 % Topical

Indications